CLDX
Celldex Therapeutics Inc
Price:  
22.00 
USD
Volume:  
978,039.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLDX EV/EBITDA

-325.9%
Upside

As of 2025-07-07, the EV/EBITDA ratio of Celldex Therapeutics Inc (CLDX) is -6.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLDX's latest enterprise value is 1,443.44 mil USD. CLDX's TTM EBITDA according to its financial statements is -213.94 mil USD. Dividing these 2 quantities gives us the above CLDX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.8x - 13.6x 13.2x
Forward P/E multiples 15.0x - 20.6x 17.8x
Fair Price (48.08) - (43.57) (49.69)
Upside -318.5% - -298.0% -325.9%
22.00 USD
Stock Price
(49.69) USD
Fair Price

CLDX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -6.75
2025-07-02 -6.78
2025-07-01 -6.50
2025-06-30 -6.23
2025-06-27 -6.22
2025-06-26 -6.49
2025-06-25 -6.58
2025-06-24 -6.64
2025-06-23 -6.25
2025-06-20 -6.28
2025-06-18 -6.38
2025-06-17 -6.14
2025-06-16 -6.23
2025-06-13 -6.52
2025-06-12 -6.23
2025-06-11 -6.26
2025-06-10 -6.41
2025-06-09 -6.35
2025-06-06 -6.55
2025-06-05 -5.98
2025-06-04 -6.02
2025-06-03 -6.09
2025-06-02 -6.12
2025-05-30 -6.06
2025-05-29 -6.08
2025-05-28 -5.71
2025-05-27 -6.06
2025-05-23 -6.23
2025-05-22 -6.24
2025-05-21 -6.11
2025-05-20 -6.28
2025-05-19 -6.41
2025-05-16 -6.27
2025-05-15 -6.16
2025-05-14 -5.80
2025-05-13 -6.01
2025-05-12 -6.18
2025-05-09 -5.61
2025-05-08 -5.98
2025-05-07 -5.79
2025-05-06 -5.63
2025-05-05 -6.22
2025-05-02 -6.33
2025-05-01 -6.35
2025-04-30 -6.38
2025-04-29 -6.41
2025-04-28 -6.55
2025-04-25 -5.99
2025-04-24 -6.00
2025-04-23 -5.95